---
layout: entry
title: "Covid-19 and drug therapy, what we learned"
link: "https://doi.org/10.1007/s11096-020-01049-6"
author:
- Provenzani, Alessio; Polidori, Piera

summary:
- "Currently, there is still no licensed specific antiviral treatment for the human coronavirus disease and a vaccine will not be ready soon. Clinical trials for future therapies are still ongoing. Prevention, control, active communication and investment in research are the only ways to overcome this challenge. Currently there is currently no licensed special treatment for COVID-19. Some treatment options have been tried with some efficacy."

original:
- "COVID-19, the disease associated in December 2019 with the novel coronavirus SARS-CoV-2, was observed for the first time in China and then spread worldwide becoming pandemic. Currently, there is still no licensed specific antiviral treatment for the human coronavirus disease and a vaccine will not be ready soon. However, based on experience from the use of other antiviral agents to treat similar virusses, some treatment options have been tried with some efficacy. Clinical trials for future therapies are still ongoing. In the meantime, prevention, control, active communication and investment in research are the only ways to overcome this challenge."
---

